Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Curious about accumulating points? Learn which card is best for accumulating points and elevate your rewards strategy effectively.
24,231 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
OKX now lets traders access major US stocks around the clock using cryptocurrency as collateral. The new feature deli...
A high-profile export case links AI hardware, sanctions, and risk for investors. This article breaks down what happen...
FuboTV has faced a brutal stretch, yet new synergies from Disney and Hulu may set up a rebound in EBITDA and subscrib...
A major offshore drilling reshuffle drives Transocean higher as Valaris merges with a multi‑billion agreement. This p...
Oil climbs to the $70 range as the Fed signals a tighter stance, renewing risk-off sentiment that weighs on Bitcoin. ...
A new institutional stake in Howard Hughes Holdings suggests rising confidence in the stock. With 140,268 shares boug...
Hudbay's 2025 earnings outlook hinges on copper and zinc markets, mine costs, and capital decisions. This guide break...
Weekly pending home sales return to year-over-year growth as spring approaches, with 2026 readings pointing to renewe...
Pippin jumps 20% in a single session, bucking a broad market dip. The meme coin climbs near $0.71 with a $710 million...
A single, common misstep drains billions from retirees’ accounts each year. Learn what this simple retirement mistake...
A wealth manager reduced its position in FIXD by 86,075 shares, cutting the value by roughly $3.8 million. This artic...